Custom antibody
Development.
We develop custom antibodies against peptide targets for pharma, biotech and research partners.
CUSTOM DEVELOPER
What we
offer
Antibody development against peptide epitopes
Project-specific strategy design
Immunization and antibody generation
Initial validation for downstream applications
Why bioClonal
Specialized expertise in
peptide antibody discovery
01
Peptide-Focused Expertise Specialized antibody discovery strategies engineered for low-immunogenic and structurally challenging peptide targets.
02
Proprietary Superimmunogen Design Customized immunogen engineering approaches designed to improve immune recognition and antibody performance.
03
Flexible collaboration model
End-to-end
Custom development
retained by the client. Zero royalti stacking.
Monoclonal antibody characterization and production
Empowering the Entire
Biotech Value Chain
APPLICATIONS OF THE SERVICES
Diagnostics & Biomarker Detection
Clinical assays & platforms for early detection of neurological indicators.
Vaccine & Delivery Platforms
Targeting tags in nanoparticles and advanced drug delivery systems.
Therapeutic Development
Supporting peptide-based drugs & target validation for next-gen treatments.
Modified Peptides & Neo-epitopes
Recognizing mutations and structural variations in complex biological contexts.
Biomanufacturing
In-process monitoring & QA of peptide products at commercial scale.
Clinical Monitoring
Pharmacodynamics and assay standardization across global clinical trials.
APPLICATIONS OF THE SERVICES
Our Peptide Antibody
Discovery Workflow
Specialized workflows engineered for challenging
peptide targets and low-immunogenic epitopes.
STEP
01
Peptide & Epitope Analysis We evaluate peptide structure, immunogenicity and downstream application requirements to design the optimal discovery strategy.
STEP
02
Superimmunogen Design Customized Superimmunogens are engineered to improve immune recognition
STEP
03
Immunization & Screening Optimized immunization and screening workflows maximize the probability of identifying high-specificity antibodies.
Strategic Pharma
Partnerships
Case
studies
Explore some of the research projects we work on: from RNA therapies and immunotherapy to antibody discovery against complex targets, driven by our scientific expertise and proprietary technology.
RNA Therapies, Immunotherapy, and Advanced Diagnostics against Antimicrobial Resistance END-RAM
RNA Therapies, Immunotherapy, and Advanced Diagnostics against Antimicrobial Resistance END-RAM
High homology
peptide target
With RedMabs, far more clones were obtained (42 vs. 2), and unlike the standard method, several showed high affinity.
Antibody Discovery
Rational Antibody Discovery Novel Target for Alzheimer Disease reachable with RedMabs
TechnicalFAQs
BioClonal provides end-to-end custom peptide antibody development services tailored to the biological complexity of each target and its intended downstream application. Projects may include peptide analysis, proprietary Superimmunogen design, immunization, screening, monoclonal antibody generation and application-focused validation workflows. Each program is customized according to the client’s scientific objectives and project requirements.
Yes. BioClonal designs validation workflows according to the final application requirements of each project. Antibodies can be characterized and validated for applications including ELISA, Western Blot, Immunohistochemistry (IHC), Immunofluorescence (IF) and diagnostic assay development. Our peptide-focused validation strategies are designed to maximize specificity, reproducibility and downstream performance.
BioClonal operates through flexible scientific partnership models adapted to the needs of biotech, pharmaceutical and diagnostic companies. We work closely with each partner throughout the antibody discovery process, providing direct scientific interaction, customized workflows and application-oriented project development.
Clients retain full intellectual property ownership under a straightforward fee-for-service structure.
Projects can typically begin with a peptide sequence and basic information about the intended downstream application. BioClonal evaluates peptide characteristics, target biology and validation requirements to design a customized Superimmunogen and antibody discovery strategy optimized for the project objectives.